In January 2020, Forbes predicted the Cannabidiol (CBD) industry sales pertaining to the hemp-derived products to be $450 million for the year 2020, however, a Global News Wire report from September 2020 indicated that the hemp-derived CBD products trade was worth $526.3 million in 2020. A partnered study by Hemp Industry Daily and Nielsen expects the industry to soar to $6.9 billion by 2025.
Another report on the industry by the Global News Wire from late 2020 asserts that the industry showed 38% growth from 2019 with sales projected to reach @19.7 billion despite the difficulties of the pandemic, the forecast was made by BDSA, a trusted market intelligence entity having its expertise in the cannabis market. With a Compounded Annual Growth Rate (CAGR) of 22%, BDSA also predicts that global sales would reach $47.2 billion in 2025. With a CAGR of 18%, the US market alone is expected to be $34.5 billion by 2025.
Within the past few years, cannabis has been making a transformation from once being an illicit controlled substance towards being an alternative therapeutic choice. The medical and health benefits of cannabis and CBD products are being researched and proven by widespread adoption. This in turn has been an awareness-driven phenomenon whereby cannabis and CBD therapies emerged as alternatives to pharmaceuticals, with an added benefit of little to no side-effects.
was founded by Todd Davis in 2014, his biotech background beginning in the 90s and his belief in CBD entered him into the CBD industry with the participation of CBD Unlimited in the Hemp Pilot Program of 2014. His company is a pioneer within the industry, grappling and solving the complex industrial puzzle of dosage. Through several statistical analysis studies of 180 volunteer patients, CBD Unlimited has achieved proprietary formulation for its varied range of products. The lineup includes CBD Oils, Concentrates, Topicals, CBD Premium Blue, and CBD for Pets. The US government, through the 2018 Farm Bill, legalized the production and sale of hemp-derived CBD products.
An industry critique, The CBD Nerds, commends CBD Unlimited’s products and expertise and states the competitive advantage the company has over its competitors, declaring that the company has the “highest quality CBD products on the market”. A UN vote to remove cannabis and cannabis resin from Schedule IV of 1961 came in December 2020 after the company received two provisional licenses to operate in Jamaica in October are merely some of the positive developments for the industry leader. The company has had several important developments within the industry go in its favor, the CEO disclosed in 2019 that they are targeting a wider distribution network, and expanding internationally. Observing the recent performance and developments, CBD Unlimited definitely achieved the stated goals. The second-largest pharmacy store chain in North America, Walgreens also houses CBD Unlimited products, BalmX, and MistX, both in-store and online. With more than 9000 locations and a strong online presence, Walgreens is poised to be a major distribution node of CBD Unlimited products. The company is exponentially expanding its distribution of all its products, the CBD for Pets lineup is now being made available nationwide at pet supply stores and at veterinary clinics as well. The parent company, Endexx Corporation also announced a joint venture with the music industry legend and a seasoned entrepreneur, DJ Khaled.
The company has posted significant and continuous growth in terms of sales revenue, it has been working to reduce the cost of sales through optimizing its international operations, and through improving the nodes within its supply chain. CBD Unlimited is a perfect underdog to invest in since it is perfectly positioned to cultivate the benefits of the booming industry.
CBD Unlimited is positioned perfectly for exponential growth in 2021 and onward. The company is a pioneer in business since 2014. The use of scientific methodology to process the highest quality ingredients has enabled the company to achieve a strong reputation within the industry. CBD Unlimited has distribution through several channels, online through its own e-store, through Walgreen’s’ online store, through several thousand store locations, pet supply stores, and through veterinary clinics. Having a multi-nodal distribution structure, the company is an ideal candidate to appropriate a huge share of a rampantly growing industry.
The market has welcomed their most recent products, the “Best Value” line formulated at 400mg with an SRP at $19.99 and the Premium CBD Unlimited “Most Complete” line formulated at 1,000 mg. Both these lines have a high potential for growth in 2021 which, complimented with the expanding distribution, would translate into revenue growth for the company. Collectively the lines cover a wide range of potential customers. With the pandemic taking a toll on disposable incomes, the Best Value line offers an affordable therapeutic solution. CEO Todd Davis declares that the company is committed to delivering the best in CBD.
While CBD Unlimited is already in at least 6000 stores nationwide, it aims to snowball towards more than 20,000 locations by the end of 2021, with a long-term target of 100,000 stores. The company has also secured a major convenience partner expecting to hit the shelves in March 2021 with a Grab-N-Go CBD 125mg Balm at the MSRP of $5.99. CBD Unlimited is also working with their distributor, other F/D/M, and convenience channels to expand the Grab-N-Go segment with their new “Green Line”. The company believes this to be a major growth opportunity and is determined to harness the potential through aggressively expanding its distribution.
